Product information

Current status:

Cancelled Post Market

Current status date:

2001-05-22

Original market date: ^{See footnote 1}

1997-02-04

Product name:

METHOTREXATE-PWS IM IV IAR INT IVR 20MG/VIAL

DIN:

02170655 Electronic product monograph is not available

Company:

WYETH-AYERST CANADA INC.
1025 Marcel Laurin Blvd.
St. Laurent
Quebec
Canada H4R 1J6

Class:

Human

Dosage form(s):

Powder For Solution

Route(s) of administration:

Intrathecal ,  Intra-Arterial ,  Intramuscular ,  Intravenous

Number of active ingredient(s):

1

Schedule(s):

Prescription

American Hospital Formulary Service (AHFS): ^{See footnote 3}

10:00.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

L01BA01 METHOTREXATE

Active ingredient group (AIG) number:^{See footnote5}

0107545003